Developer docs
API playgroundTry for free, no card

Search company profiles

SyncThink

Full company profile

uuid0003cvx

Namestring
SyncThink
Legal namestring
NeuroSync Inc.
Websiteurl
syncthink.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

SyncThink, operating under the legal entity NeuroSync Inc. and headquartered in Palo Alto, California, is a private digital health company that has built the FDA-cleared EYE-SYNC platform — a wireless VR-based system that objectively measures eye movements to assess brain health, detect concussions, and support clinical decision-making. The platform combines proprietary XR hardware, AI-powered analytics, and customizable reports, with each assessment reportedly completed in under one minute and validated at a 0.9 test-retest reliability. Independent research validation of the underlying quantification methods is highlighted on the company's marketing materials.

The company sells to four primary verticals: Healthcare Providers (hospitals and specialty clinics for concussion assessment, vestibular therapy, and brain health diagnostics), Sports Organizations (university and professional athletic programs for athlete safety), Military (active duty cognitive performance optimization), and Biopharma (CNS clinical trial endpoints and drug response monitoring). Named customers include Massachusetts General Hospital, Houston Methodist, Sutter Health, St. David's Medical Center, Rice University, Georgia Tech, and Virginia Tech, alongside specialty clinics such as the Kutcher Clinic for Sports Neurology and the Kaizen Brain Center.

The business model is enterprise B2B direct sales with a "Request a Demo" engagement motion, monetizing through bundled VR hardware and proprietary software/analytics sales. Pricing is not publicly disclosed, consistent with a consultative sales approach targeting larger institutional contracts. The company was founded in 2009, remains private, and operates with a 1–10 employee team, with disclosed funding of approximately $3.6 million across rounds from Quadrant Management, Oceanic Partners, MassChallenge, and StartUp Health, the most recent dated 2019.

Short descriptiontext

SyncThink (legal: NeuroSync Inc.) provides the FDA-cleered [cleared] EYE-SYNC VR-based eye-tracking platform for objective brain health and concussion assessment. It serves healthcare providers, sports organizations, the military, and biopharma customers through enterprise direct sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHolliston, United States
HQ citystring
Holliston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
digital health diagnostics, VR eye tracking platform, concussion assessment technology, brain health analytics, neurotechnology solutions
Industry4 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Industrial Instruments For Measurement, Display, And Control3823
  • Computer Peripheral Equipment, Nec3577
Product category
Digital Health Neurotechnology
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1VR Platform and Software Sales
TypeHardware Sales
Description

Sale of VR hardware (XR hardware) combined with proprietary software and analytics. The platform is customized for various use cases including healthcare, sports, military, and biopharma applications.

neurosync.health
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1EYE-SYNC
Description

FDA-cleared VR-based eye tracking assessment platform for concussion diagnosis and brain health monitoring

neurosync.health
Core offering1 text field

SyncThink sells the EYE-SYNC platform, an FDA-cleared, VR-based eye-tracking assessment system that objectively measures eye movements to evaluate brain health, diagnose concussions, and support clinical and performance decision-making. The offering bundles wireless XR hardware with proprietary AI-powered software and analytics and customizable reports, delivered as enterprise solutions for healthcare providers, sports organizations, the military, and biopharma companies. Assessments complete in under one minute with 0.9 test-retest reliability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 0.9 test-retest reliability for all assessments
+1 more record
Product overview1 text field

NeuroSync offers a digital health platform for assessing brain health and optimizing performance. The core product is EYE-SYNC, an FDA-cleared VR-based system that objectively measures eye movements to detect neurological deficits and support clinical decision-making. The platform consists of wireless XR Hardware, Software & Analytics powered by AI, and Customizable Reports. The product portfolio includes Neuro Health for healthcare and clinical research applications, and Brain Performance for sports, military, and high-performance optimization use cases. All assessments are completed in under a minute with validated metrics showing 0.9 test-retest reliability.

Product and service3 records
1EYE-SYNC
CategoryDigital Health Neurotechnology Platform
Description

FDA-cleared VR-based assessment platform that objectively measures eye movements to evaluate brain health, detect concussions, and support clinical decision-making. The system uses proprietary algorithms and quantification methods validated in independent research, with assessments completed in under one minute and 0.9 test-retest reliability. Targeted at healthcare providers, sports programs, military, and biopharma researchers.

2Neuro Health
CategoryClinical Brain Health Solution
Description

Brain health assessment solution designed for healthcare providers to support advanced patient care and clinical research, enabling objective diagnostics for neurological conditions. Targeted at hospitals, clinics, and academic medical centers running neurology and sports neurology practices.

3Brain Performance
CategoryPerformance Optimization Solution
Description

Performance optimization solution for sports organizations, military, and high-performance specialists to assess and optimize brain function and decision-making capabilities. Targeted at universities, professional sports teams, and defense organizations.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Oculogica develops FDA-cleared eye-tracking-based concussion and brain injury assessment tools that compete directly with SyncThink's EYE-SYNC platform. Both target the same clinical and sports customer base with VR-style eye-movement analytics.

TypeDirect peer
Description

ImPACT Applications is the dominant FDA-cleared computerized concussion assessment tool used across collegiate and professional sports. It competes with SyncThink in concussion management for schools, sports organizations, and military.

TypeDirect peer
Description

BrainScope offers FDA-cleared EEG-based brain injury assessment devices used in hospital and military settings. It overlaps with SyncThink's clinical and military verticals as an objective brain-diagnostic alternative.

TypeDirect peer
Description

King-Devick provides an eye-movement-based sideline concussion screening test used widely in sports. It targets the same athlete safety and concussion-management use case as SyncThink's Brain Performance module.

TypeDirect peer
Description

Sway Medical delivers mobile balance and reaction-time-based concussion assessment apps used by athletic programs. It competes for the same sports and university concussion-management budget as SyncThink.

6Mindstrong
TypeEmerging player
Description

Mindstrong developed digital biomarkers for neuropsychiatric conditions using smartphone-based interactions, an emerging alternative to clinic-visit brain health assessment. It overlaps with SyncThink's objective-neuroassessment positioning.

TypeEmerging player
Description

Altoida provides FDA Breakthrough-designated digital cognitive assessment tools using smartphone AR for neurodegenerative disease detection. It competes in the broader neurological-assessment category with SyncThink.

TypeEmerging player
Description

C3 Logix offers a multi-modal concussion assessment tablet platform used by schools and sports programs, overlapping with SyncThink's sports and education verticals.

TypeBroad incumbent
Description

Akili Interactive delivers FDA-cleared digital therapeutics (EndeavorRx) for cognitive conditions, operating in the same digital-neurohealth category as SyncThink. Both pursue FDA-cleared digital solutions for brain health.

TypeOthers
Description

Tobii is a global leader in eye-tracking technology and hardware, named as a partner/technology logo for NeuroSync. It is an enabling technology supplier to SyncThink's EYE-SYNC platform rather than a competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SyncThink

Digital Health Neurotechnologysyncthink.com

SyncThink (legal: NeuroSync Inc.) provides the FDA-cleered [cleared] EYE-SYNC VR-based eye-tracking platform for objective brain health and concussion assessment. It serves healthcare providers, sports organizations, the military, and biopharma customers through enterprise direct sales.

What SyncThink does

SyncThink, operating under the legal entity NeuroSync Inc. and headquartered in Palo Alto, California, is a private digital health company that has built the FDA-cleared EYE-SYNC platform — a wireless VR-based system that objectively measures eye movements to assess brain health, detect concussions, and support clinical decision-making. The platform combines proprietary XR hardware, AI-powered analytics, and customizable reports, with each assessment reportedly completed in under one minute and validated at a 0.9 test-retest reliability. Independent research validation of the underlying quantification methods is highlighted on the company's marketing materials.

The company sells to four primary verticals: Healthcare Providers (hospitals and specialty clinics for concussion assessment, vestibular therapy, and brain health diagnostics), Sports Organizations (university and professional athletic programs for athlete safety), Military (active duty cognitive performance optimization), and Biopharma (CNS clinical trial endpoints and drug response monitoring). Named customers include Massachusetts General Hospital, Houston Methodist, Sutter Health, St. David's Medical Center, Rice University, Georgia Tech, and Virginia Tech, alongside specialty clinics such as the Kutcher Clinic for Sports Neurology and the Kaizen Brain Center.

The business model is enterprise B2B direct sales with a "Request a Demo" engagement motion, monetizing through bundled VR hardware and proprietary software/analytics sales. Pricing is not publicly disclosed, consistent with a consultative sales approach targeting larger institutional contracts. The company was founded in 2009, remains private, and operates with a 1–10 employee team, with disclosed funding of approximately $3.6 million across rounds from Quadrant Management, Oceanic Partners, MassChallenge, and StartUp Health, the most recent dated 2019.

SyncThink firmographics

Firmographics
Name
SyncThink
Legal name
NeuroSync Inc.
Website
https://syncthink.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
SyncThink (legal: NeuroSync Inc.) provides the FDA-cleered [cleared] EYE-SYNC VR-based eye-tracking platform for objective brain health and concussion assessment. It serves healthcare providers, sports organizations, the military, and biopharma customers through enterprise direct sales.
Ownership category
akta.pro rank

SyncThink industry classification

Industry
Product category
Digital Health Neurotechnology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Industrial Instruments For Measurement, Display, And Control (3823), Computer Peripheral Equipment, Nec (3577)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYMPAFAGAG
VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics)
Media, Entertainment & Sports/Gaming & Interactive Entertainment (Video Games, Esports)/Gaming Hardware & Peripherals (Consoles, PCs, Controllers, VR)

Keywords

  • Digital health diagnostics
  • VR eye tracking platform
  • Concussion assessment technology
  • Brain health analytics
  • Neurotechnology solutions

Where SyncThink is headquartered

Location

Headquarters

HQ city
Holliston
HQ country
United States
HQ region
North America

Markets served

SyncThink business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. VR Platform and Software Sales: Sale of VR hardware (XR hardware) combined with proprietary software and analytics. The platform is customized for various use cases including healthcare, sports, military, and biopharma applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

SyncThink product offering

Product offering

Core offering

SyncThink sells the EYE-SYNC platform, an FDA-cleared, VR-based eye-tracking assessment system that objectively measures eye movements to evaluate brain health, diagnose concussions, and support clinical and performance decision-making. The offering bundles wireless XR hardware with proprietary AI-powered software and analytics and customizable reports, delivered as enterprise solutions for healthcare providers, sports organizations, the military, and biopharma companies. Assessments complete in under one minute with 0.9 test-retest reliability.

Product overview

NeuroSync offers a digital health platform for assessing brain health and optimizing performance. The core product is EYE-SYNC, an FDA-cleared VR-based system that objectively measures eye movements to detect neurological deficits and support clinical decision-making. The platform consists of wireless XR Hardware, Software & Analytics powered by AI, and Customizable Reports. The product portfolio includes Neuro Health for healthcare and clinical research applications, and Brain Performance for sports, military, and high-performance optimization use cases. All assessments are completed in under a minute with validated metrics showing 0.9 test-retest reliability.

Differentiator

Problem solved

Functional benefit

Brands

  • EYE-SYNC: FDA-cleared VR-based eye tracking assessment platform for concussion diagnosis and brain health monitoring

Products and services

  • EYE-SYNC FDA-cleared VR-based assessment platform that objectively measures eye movements to evaluate brain health, detect concussions, and support clinical decision-making. The system uses proprietary algorithms and quantification methods validated in independent research, with assessments completed in under one minute and 0.9 test-retest reliability. Targeted at healthcare providers, sports programs, military, and biopharma researchers.
  • Neuro Health Brain health assessment solution designed for healthcare providers to support advanced patient care and clinical research, enabling objective diagnostics for neurological conditions. Targeted at hospitals, clinics, and academic medical centers running neurology and sports neurology practices.
  • Brain Performance Performance optimization solution for sports organizations, military, and high-performance specialists to assess and optimize brain function and decision-making capabilities. Targeted at universities, professional sports teams, and defense organizations.

Quantifiable outcome

  • 0.9 test-retest reliability for all assessments
  • +1 more outcomes

Companies that use SyncThink

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

SyncThink technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

SyncThink partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

SyncThink competitors and assessment

Company assessment

Direct peers

  • Oculogica: Oculogica develops FDA-cleared eye-tracking-based concussion and brain injury assessment tools that compete directly with SyncThink's EYE-SYNC platform. Both target the same clinical and sports customer base with VR-style eye-movement analytics.
  • ImPACT Applications: ImPACT Applications is the dominant FDA-cleared computerized concussion assessment tool used across collegiate and professional sports. It competes with SyncThink in concussion management for schools, sports organizations, and military.
  • BrainScope: BrainScope offers FDA-cleared EEG-based brain injury assessment devices used in hospital and military settings. It overlaps with SyncThink's clinical and military verticals as an objective brain-diagnostic alternative.
  • King-Devick Technologies: King-Devick provides an eye-movement-based sideline concussion screening test used widely in sports. It targets the same athlete safety and concussion-management use case as SyncThink's Brain Performance module.
  • Sway Medical: Sway Medical delivers mobile balance and reaction-time-based concussion assessment apps used by athletic programs. It competes for the same sports and university concussion-management budget as SyncThink.

Emerging players

  • Mindstrong: Mindstrong developed digital biomarkers for neuropsychiatric conditions using smartphone-based interactions, an emerging alternative to clinic-visit brain health assessment. It overlaps with SyncThink's objective-neuroassessment positioning.
  • Altoida: Altoida provides FDA Breakthrough-designated digital cognitive assessment tools using smartphone AR for neurodegenerative disease detection. It competes in the broader neurological-assessment category with SyncThink.
  • C3 Logix: C3 Logix offers a multi-modal concussion assessment tablet platform used by schools and sports programs, overlapping with SyncThink's sports and education verticals.

Broad incumbents

  • Akili Interactive: Akili Interactive delivers FDA-cleared digital therapeutics (EndeavorRx) for cognitive conditions, operating in the same digital-neurohealth category as SyncThink. Both pursue FDA-cleared digital solutions for brain health.

Others

  • Tobii: Tobii is a global leader in eye-tracking technology and hardware, named as a partner/technology logo for NeuroSync. It is an enabling technology supplier to SyncThink's EYE-SYNC platform rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

SyncThink social profiles

Digital presence

SyncThink compliance and trust

Trust signal

Compliance1 record

SyncThink financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SyncThink leadership team

Management profile

Number of profiles

Profiles4 records

SyncThink funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SyncThink M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SyncThink

What does SyncThink do?

SyncThink sells the EYE-SYNC platform, an FDA-cleared, VR-based eye-tracking assessment system that objectively measures eye movements to evaluate brain health, diagnose concussions, and support clinical and performance decision-making. The offering bundles wireless XR hardware with proprietary AI-powered software and analytics and customizable reports, delivered as enterprise solutions for healthcare providers, sports organizations, the military, and biopharma companies. Assessments complete in under one minute with 0.9 test-retest reliability.

Is SyncThink a public or private company?

SyncThink is a private company. It is classified as venture growth investor backed and is currently operating.

When was SyncThink founded?

SyncThink was founded in 2022. It employs 11 to 50 people.

Where is SyncThink based?

SyncThink is headquartered in Holliston, United States, in the North America region.

How does SyncThink make money?

One revenue line is on record: VR Platform and Software Sales.

Who are SyncThink's main competitors?

Direct peers on record are Oculogica, ImPACT Applications, BrainScope, King-Devick Technologies and Sway Medical. Emerging players are Mindstrong, Altoida and C3 Logix. Akili Interactive is listed as a broad incumbent. Tobii is listed as an others.

Does SyncThink have an API?

No public API is recorded for SyncThink.

What industry is SyncThink in?

SyncThink's product category is Digital Health Neurotechnology. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SeedtableExplore 69 Best Neurotechnology Startups to watch in 2025. Discover innovative companies, funding insights, and industry trends.Flow Neuroscience, a medical technology company based in Malmö, Sweden, has raised $2.6 million for its innovative depression treatment combining brain stimulation and app-based therapy. Other notable startups mentioned include Neurofenix, which raised $14.0 million for a rehabilitation device, and SyncThink, which developed a concussion monitoring platform funded with $3.5 million.FierceBiotechSyncThink's brain-testing VR tech goes international with European approvalSyncThink's Eye-Sync VR system, which uses AI to assess neurological conditions via eye movements, received CE mark approval in Europe. The FDA-cleared platform can diagnose conditions like ADHD, autism, Parkinson's, and dementia, and is now expanding into augmented reality with Magic Leap.The VergeNeurotech company will use Magic Leap 2 for dizzinessMagic Leap granted four healthcare partners, including neurotech firm SyncThink, early access to its Magic Leap 2 headset. SyncThink will use the device's upgraded cameras and sensors to track eye movements for diagnosing vestibular disorders, with potential VR-based treatments. The company also plans to collaborate on clinical studies.FierceBiotechSyncThink clocks FDA nod for concussion test based on AI-powered eye trackingThe FDA cleared SyncThink's Eye-Sync platform for diagnosing concussion and mild traumatic brain injury using AI-powered eye tracking. The system, validated in a study of over 1,600 patients, detects concussions with at least 82% sensitivity and identifies non-concussion patients with over 93% specificity.Small Business SolutionsSome Cool Tech Makes Good on its Promises in January, Some Doesn’tCES 2019 tech products are reviewed for January 2020, with 5G showing little progress and foldable phones still limited. Wiser Systems was selected by NASA, Burger King sold the Impossible Whopper, and VR devices like Vive Pro Eye and SyncThink's EYE-SYNC advanced in business uses.SfchronicleThe Future of Football: What will the game look like?The article examines the potential evolution of American football over the next two to three decades, driven by declining participation rates and increasing concerns regarding concussions and chronic traumatic encephalopathy (CTE). It highlights emerging safety innovations, including high-tech sensors from companies like Vicis and SyncThink, modified tackling techniques promoted by Atavus Sports, and rule changes aimed at reducing violent collisions. The report suggests that while traditional tackle football may persist, the sport could increasingly incorporate flag football formats or advanced protective equipment to ensure its long-term viability.Inc.This Gadget Knows When Players Have a Concussion. Will the NFL Take Note?SyncThink's EyeSync headset detects concussions by tracking eye movement, and will be used by college football teams this fall. The device has raised $36 million from the Department of Defense and $6.7 million in VC funding. The startup aims to reduce athlete injury rates.Atlanta Journal-ConstitutionUGA joins concussion monitoring programThe University of Georgia joined a concussion monitoring program with SyncThink, covering all 19 athletic programs. The partnership includes EYE-SYNC technology that detects visual impairments in under a minute. The program follows Georgia defensive back Rashad Roundtree's departure after multiple concussions.SfchronicleNew technology helping Warriors diagnose concussionsThe Golden State Warriors used the Eye-Sync optical scanner to clear guard Patrick McCaw after a concussion, tracking his eye movements to assess impairment. The device, produced by SyncThink, provides results in a minute and is the first NBA team to adopt it. The Warriors also note the NBA's concussion protocol and the difficulty of detecting delayed symptoms.